Viewing Study NCT05511350


Ignite Creation Date: 2025-12-24 @ 4:48 PM
Ignite Modification Date: 2026-02-02 @ 9:03 AM
Study NCT ID: NCT05511350
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2022-10-18
First Post: 2022-08-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access Protocol for Subjects With Relapsed or Refractory Advanced Solid Tumors Receiving TJ210001
Sponsor: I-Mab Biopharma US Limited
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumor Metastatic Cancer Advanced Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None monoclonal antibody anti-C2aR View